Tendencias en la prescripción y el uso de fármacos antiepilépticos en adultos mayores con epilepsia de reciente diagnóstico

Olesen, 2003, The burden of brain diseases in Europe, Eur J Neurol., 10, 471, 10.1046/j.1468-1331.2003.00682.x Hauser, 1993, The incidence of epilepsy and unprovoked seizures in Rochester, Minnesota, 1935-84, Epilepsia, 34, 453, 10.1111/j.1528-1157.1993.tb02586.x Craig, 1991, General practice management of adult-onset. Epilepsy analysed, Care Elderly, 3, 69 National Institute for Clinical Excellence. The epilepsies: The diagnosis and management of the epilepsies in adults and children in primary and secondary care. NICE clinical guidelines 137. London: National Institute for Clinical Excellence; 2012. Semah, 2004, The choice of antiepileptic drugs in newly diagnosed epilepsy: A national French survey, Epileptic Disord, 6, 255 French, 2004, Neurology, 62, 1252, 10.1212/01.WNL.0000123693.82339.FC Karceski, 2005, Treatment of epilepsy in adults: Expert opinion, 2005, Epilepsy Behav., 7, S1, 10.1016/j.yebeh.2005.06.001 Glauser, 2006, ILAE treatment guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes, Epilepsia, 47, 1094, 10.1111/j.1528-1167.2006.00585.x Pugh, 2006, Prescribing antiepileptics for the elderly: Differences between guideline recommendations and clinical practice, Drugs Aging, 23, 861, 10.2165/00002512-200623110-00002 Perucca, 2011, The pharmacological treatment of epilepsy in adults, Lancet Neurol., 10, 446, 10.1016/S1474-4422(11)70047-3 Boon, 2012, Recommendations for the treatment of epilepsy in adult patients in general practice in Belgium: An update, Acta Neurol Belg., 112, 119, 10.1007/s13760-012-0070-9 Glauser, 2013, ILAE Subcommission on AED Guidelines. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes, Epilepsia, 54, 551, 10.1111/epi.12074 Kwan, 2010, Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies, Epilepsia, 51, 1069, 10.1111/j.1528-1167.2009.02397.x Rochat, 2001, Antiepileptic drug utilization: A Danish prescription database analysis, Acta Neurol Scand., 104, 6, 10.1034/j.1600-0404.2001.00197.x Oun, 2006, Use of antiepileptic drugs in Estonia: An epidemiologic study of adult epilepsy, Eur J Neurol., 13, 465, 10.1111/j.1468-1331.2006.01268.x Tsiropoulos, 2006, Trends in utilization of antiepileptic drugs in Denmark, Acta Neurol Scand., 114, 70 Savica, 2007, Prescribing patterns of antiepileptic drugs in Italy: A nationwide population-based study in the years 2000-2005, Eur J Neurol., 14, 1317, 10.1111/j.1468-1331.2007.01970.x Alacqua, 2009, Newer and older antiepileptic drug use in Southern Italy: A population-based study during the years 2003-2005, Epilepsy Res., 85, 107, 10.1016/j.eplepsyres.2009.03.002 Hsieh, 2009, Antiepileptic drug utilization in Taiwan: Analysis of prescription using National Health Insurance database, Epilepsy Res, 84, 21, 10.1016/j.eplepsyres.2008.11.018 Landmark, 2009, Antiepileptic drugs in epilepsy and other disorders a population-based study of prescriptions, Epilepsy Res., 87, 31, 10.1016/j.eplepsyres.2009.07.005 Johannessen Landmark, 2011, Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population, Epilepsy Res., 95, 51, 10.1016/j.eplepsyres.2011.02.012 Strzelczyk, 2013, Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany, Epilepsy Behav, 27, 433, 10.1016/j.yebeh.2013.03.007 Pugh, 2008, Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000-2004, Neurology., 70, 2171, 10.1212/01.wnl.0000313157.15089.e6 Besocke, 2013, Outcome of newly-diagnosed epilepsy in older patients, Epilepsy Behav., 27, 29, 10.1016/j.yebeh.2012.11.041 Stephen, 2006, Pharmacological outcomes in older people with newly diagnosed epilepsy, Epilepsy Behav, 8, 434, 10.1016/j.yebeh.2005.11.007 Saetre, 2007, An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly, Epilepsia, 48, 1292, 10.1111/j.1528-1167.2007.01128.x Bonnett, 2012, Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: Post-hoc, subgroup analyses of data from the SANAD trial, Lancet Neurol, 4, 331, 10.1016/S1474-4422(12)70018-2